The Sophiris Boondoggle
November 13, 2015 at 21:56 PM EST
A brief column, if I may, to capture the teachable moment offered to us by the release of 52-week data from Sophiris ($SPHS). Longer-term readers recall that we first introduced Sophiris as a long investment idea on 30 November 2014. The company had taken an unusual toxin, called aerolysin, from the freshwater bacteria Aeromonas that, when activated, […]
